# Platelet Inhibitory Effect of Clopidogrel in Patients Treated With Omeprazole, Pantoprazole, or Famotidine

> **NCT00950339** · PHASE4 · COMPLETED · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 63 (actual)

## Conditions studied

- Coronary Heart Disease
- GI Bleeding

## Interventions

- **DRUG:** omeprazole, 20mg twice daily
- **DRUG:** famotidine 40mg twice daily
- **DRUG:** pantoprazole 40mg once daily

## Key facts

- **NCT ID:** NCT00950339
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2011-06
- **Final completion:** 2011-08
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2016-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00950339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00950339, "Platelet Inhibitory Effect of Clopidogrel in Patients Treated With Omeprazole, Pantoprazole, or Famotidine". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00950339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*